Ionis Pharmaceuticals IONS Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's accounts payable?
- Ionis Pharmaceuticals (IONS) reported accounts payable of -$3.1M in Q1 2026.
- How has Ionis Pharmaceuticals's accounts payable changed year-over-year?
- Ionis Pharmaceuticals's accounts payable increased by 88.1% year-over-year, from -$25.97M to -$3.1M.
- What does accounts payable mean?
- The change in the amount the company owes to its suppliers.
- How do you interpret accounts payable?
- An increase improves cash flow by delaying outflows, while a decrease indicates faster payment of obligations.
- How does accounts payable compare across companies?
- Standard working capital metric; peers often manage this to optimize cash conversion cycles.